Click Therapeutics
New York, United States · Healthcare, Health Care · 171 employees
Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for patients with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously
Funding history
- Series series d — $50.0M — Apr 2026
- Funding Round — $48.6M — Apr 2025
- Funding Round — $8.3M — Nov 2024
- Series seed — $3.0M — Nov 2024
- Funding Round — $15.0M — Apr 2022
Recent signals
- Apr 09, 2026: Raised $50.0M in Series series d
- Apr 01, 2025: Raised $48.6M
- Nov 21, 2024: Raised $8.3M
- Nov 21, 2024: Raised $3.0M in Series seed
- Oct 30, 2024: Launched Click Therapeutics Launches Click SE™ Offering with Software-Enhanced Drug™ Therapies to Innovate Prescription Digital Therapeutics.
- May 22, 2024: Acquired Click Therapeutics, Inc. accelerates expansion into Obesity and Cardiometabolic Disease with acquisition of Better Therapeutics, Inc.'s assets
- Apr 15, 2022: Raised $15.0M
- Nov 05, 2021: Raised $52.1M
See plans & pricing → Track Click Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.